Lin, Richard J. http://orcid.org/0000-0002-0834-7880
Elko, Theresa A.
Devlin, Sean M.
Shahrokni, Armin
Jakubowski, Ann A.
Dahi, Parastoo B.
Perales, Miguel-Angel
Tamari, Roni
Shaffer, Brian C.
Sauter, Craig S.
Papadopoulos, Esperanza B.
Gyurkocza, Boglarka
Korc-Grodzicki, Beatriz
Barker, Juliet N.
Maloy, Molly A.
Giralt, Sergio A.
Article History
Received: 8 July 2019
Revised: 7 August 2019
Accepted: 12 August 2019
First Online: 30 August 2019
Compliance with ethical standards
:
: SAG reports research funding from Amgen, Actinium, Celgene, Johnson & Johnson, Miltenyi Biotec, and Takeda and serves as a consultant for Amgen, Actinium, Celgene, Johnson & Johnson, Jazz Pharmaceuticals, Miltenyi Biotec, Takeda, Novartis, Kite Pharma, and Spectrum Pharmaceuticals. MAP reports honoraria from Abbvie, Bellicum, Bristol-Myers Squibb, Incyte, Merck, Novartis, Nektar Therapeutics, and Takeda. He serves on DSMBs for Servier and Medigene, and the scientific advisory boards of MolMed and NexImmune. He has also received research support for clinical trials from Incyte and Miltenyi Biotec. CSS has served as a paid consultant on advisory boards for: Juno Therapeutics, Sanofi-Genzyme, Spectrum Pharmaceuticals, Novartis, Genmab, Precision Biosciences, Kite, a Gilead Company and GSK. He has received research funds for investigator-initiated trials from: Juno Therapeutics and Sanofi-Genzyme. All other authors declare that they have no conflict of interest.